<DOC>
	<DOCNO>NCT02359448</DOCNO>
	<brief_summary>This open label clinical trial sustained-release Melatonin 2mg daily 12 week patient Parkinsons 's Disease reporting nocturia , define get regularly night &gt; twice pass urine . The primary objective study evaluate effect exogenous melatonin bother related nocturia . Secondary objective evaluate : 1 ) Mean night time urinary frequency 2 ) Volume urine void night 3 ) Incontinence low urinary tract symptom ( LUTS ) 3 ) Quality sleep 4 ) Quality life 5 ) Sleep disturbance partner 6 ) Safety</brief_summary>
	<brief_title>Melatonin Nocturia Parkinson 's Disease</brief_title>
	<detailed_description>This Phase IIb , open label single-site trial sustained-release Melatonin 2mg patient PD , report nocturia , define get regularly night &gt; twice pass urine . The primary objective study evaluate effect exogenous melatonin bother related nocturia . Secondary objective evaluate : 1 ) Mean night time urinary frequency 2 ) Volume urine void night 3 ) Incontinence low urinary tract symptom ( LUTS ) 3 ) Quality sleep 4 ) Quality life 5 ) Sleep disturbance partner 6 ) Safety . Patients ask fill questionnaire , diary wear wrist actiwatch 2 week prior start melatonin last 2 week 6 week treatment . A research nurse telephone patient weekly whilst patient Melatonin enquire medication use adverse event . After take consent , investigator take history cover urinary symptom , cause nocturia , e.g . medication . Participants examine severity PD assess use Hoehn Yahr stag UPDRS ( Unified Parkinson 's Disease Rating Scale ) . Height , weight supine/standing blood pressure record . Urodynamics perform accord ICS Good Urodynamic Practice include uroflowmetry , bladder scan , fill cystometry pressure flow study . This pilot study aim evaluate effect melatonin may nocturia related bother Parkinson 's Disease . Chi square test use analyse change bother related nocturia ( primary outcome ) number nocturia episode questionnaire score ( Secondary outcomes ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . Adults male female ( &gt; 18 year ) clinically diagnose PD accord Brain Bank Criteria 2 . Reporting nocturia NMSQuest item 9 `` Getting regularly night pas urine '' get pass urine two time night . Although International Continence Society ( ICS ) define nocturia wake night one time void , recent population base study show two void associate bother impaired health relate quality life . 3 . Able provide inform write consent 1 . Montreal Cognitive Assessment ( MOCA ) score &lt; 26 2 . History suggestive REM sleep behaviour disorder 3 . Congestive heart failure , liver failure kidney failure determine medical history 4 . Uncontrolled diabetes , significant microalbuminuria patient diabetes 5 . Using medication benzodiazepine Zdrugs ( e.g . Zaleplon , Zolpidem Zopiclone ) 6 . Presence urinary tract infection determine clinician 7 . Evidence incomplete bladder emptying , i.e. , post void residual urine 100 mL determine ultrasound ( bladder scan ) 8 . Presence significantly enlarge prostate determine clinician use European Association Urology ( EAU ) guideline base urodynamic finding 9 . Females childbearing potential must willing use effective method contraception ( hormonal barrier method birth control ; abstinence ) time consent sign 6 week treatment discontinuation . 10 . Females childbearing potential must negative pregnancy test within 7 day prior registered trial treatment . 11 . Females must breastfeed . 12 . Allergies excipients IMP 13 . Smokers 14 . Patient autoimmune disease 15 . Patients take carbamazepine , rifampicin cimetidine 16 . Patients rare hereditary problem galactose intolerance , LAP lactose deficiency galactose malabsorption 17 . Excessive alcohol consumption define investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>